Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone transdermal spray for low libido in postmenopausal women with low testosterone
ACTRN12605000481673Phase 2Completed
- Sponsor
- Fempharma
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of testosterone in hypoactive sexual desire disorder (HSDD) and Hypoandrogenism (TD) (2 arms), sponsored by Fempharma. Primary endpoint: Frequency of satisfactory sexual events compared with placebo. Started Jul 2003; status: completed.
02
Drugs
testosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)Hypoandrogenism (TD)
Beyond the preview
Go deeper on ACTRN12605000481673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000481673.